Iocide® is a novel, iodine-based, topical microbicide developed for vaginal use. Current clinical studies are focused on safety and acceptability of a single application to prevent intrapartum transmission of group B streptococcus (GBS) from mother to baby. Current strategies for prevention of early-onset GBS sepsis in the neonate require screening at 35-36 weeks and antibiotic administration during labor…
Download PDF Read More
Objective: Iocide® disinfectant solution was investigated for treatment of Pseudomonas aeruginosa biofilms using the ASTM method E2196-02, with minor modifications.
Methods: Pseudomonas aeruginosa biofilms were grown on 13 mm diameter x 1 mm thick, sterilized, hydroxyapatite disks (coupons), under the conditions of constant fluid-shear and temperature (37oC)…
Levels of bacteria detected in untreated dental unit waterlines (DUWLs) are typically μ1,000,000 colony forming units per milliliter (CFU/mL).1-3 Given that the acceptable standard for drinking water is [ 500 CFU/mL, DUWL water is generally considered unfit for human consumption…
Download PDF Read More